Acadian Asset Management’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $36K | Buy |
+22,418
| New | +$36K | ﹤0.01% | 1521 |
|
|
2020
Q2 | – | Sell |
-441
| Closed | -$85K | – | 2353 |
|
|
2020
Q1 | $85K | Buy |
441
+165
| +60% | +$31.8K | ﹤0.01% | 1383 |
|
|
2019
Q4 | $92K | Sell |
276
-251
| -48% | -$83.7K | ﹤0.01% | 1486 |
|
|
2019
Q3 | $170K | Hold |
527
| – | – | ﹤0.01% | 1356 |
|
|
2019
Q2 | $227K | Sell |
527
-61
| -10% | -$26.3K | ﹤0.01% | 1195 |
|
|
2019
Q1 | $333K | Buy |
588
+90
| +18% | +$51K | ﹤0.01% | 1221 |
|
|
2018
Q4 | $147K | Buy |
+498
| New | +$147K | ﹤0.01% | 1182 |
|